Chengdu Kanghong Pharmaceuticals Group saw no growth in patent filings and highest growth of 0.24% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.24%. GlobalData’s DataBook provides a comprehensive analysis of Chengdu Kanghong Pharmaceuticals Group’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Chengdu Kanghong Pharmaceuticals Group has been focused on protecting inventions in China(CN) with one publication in Q2 2024

The China(CN) Patent Office dominates the patent filings with nearly 100% of filings. The China(CN), European Patent Office(EPO), and United States(US) patent Office are among the top ten patent offices where Chengdu Kanghong Pharmaceuticals Group is filings its patents. Among the top granted patent authorities, Chengdu Kanghong Pharmaceuticals Group has 100% of its grants in United States(US).

Roche and Johnson & Johnson could be the strongest competitors for Chengdu Kanghong Pharmaceuticals Group

Diabetic macular edema related patents lead Chengdu Kanghong Pharmaceuticals Group portfolio followed by diabetic retinopathy, and corneal neovascularization

Chengdu Kanghong Pharmaceuticals Group has highest number of patents in diabetic macular edema followed by diabetic retinopathy, corneal neovascularization, age related macular degeneration, and branch retinal vein occlusion.

For comprehensive analysis of Chengdu Kanghong Pharmaceuticals Group's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.